Back to Search

JAE KIM, M.D.

M.D.

Neurology Physician

NPI: 1841426400IndividualAccepts Medicare

Specialties, Licenses & Credentials

Neurology PhysicianPrimary

Psychiatry & Neurology — Neurology

Code: 2084N0400X

58603(MN)ME175404(FL)10113(SD)
Vascular & Interventional Radiology Physician

Radiology — Vascular & Interventional Radiology

Code: 2085R0204X

58603(MN)
Vascular Neurology Physician

Psychiatry & Neurology — Vascular Neurology

Code: 2084V0102X

58603(MN)10113(SD)

CMS Specialties

PrimaryNEUROLOGY

Education

OTHER

Class of 2009

Clinical Trials (1)

1
Linked Trials
0
Recruiting
0
With Results

Risankizumab Long-term Remission Study

NCT04630652ACTIVE_NOT_RECRUITINGPHASE4PRINCIPAL_INVESTIGATOR

Research & Publications (20)

Psoriasis harbors multiple pathogenic type 17 T-cell subsets: Selective modulation by risankizumab.
PMID 39978685·J Allergy Clin Immunol·2025
8-other
Proportion of CD4CD49bLAG-3Type 1 Regulatory T Cells in the Blood of Psoriasis Patients Inversely Correlates with Psoriasis Area and Severity Index.
PMID 29890167·J Invest Dermatol·2018
8-other
Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials.
PMID 30097359·Lancet·2018
3-trial
Reduction of Inflammatory and Cardiovascular Proteins in the Blood of Patients with Psoriasis: Differential Responses between Tofacitinib and Etanercept after 4 Weeks of Treatment.
PMID 28927890·J Invest Dermatol·2018
3-trial
Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis.
PMID 28423301·N Engl J Med·2017
3-trial
Highly Effective New Treatments for Psoriasis Target the IL-23/Type 17 T Cell Autoimmune Axis.
PMID 27686018·Annu Rev Med·2017
6-review
The Spectrum of Mild to Severe Psoriasis Vulgaris Is Defined by a Common Activation of IL-17 Pathway Genes, but with Key Differences in Immune Regulatory Genes.
PMID 27185339·J Invest Dermatol·2016
4-observational
Molecular Phenotyping Small (Asian) versus Large (Western) Plaque Psoriasis Shows Common Activation of IL-17 Pathway Genes but Different Regulatory Gene Sets.
PMID 26763436·J Invest Dermatol·2016
4-observational
Patients With Psoriasis and Personalized Trade-offs in Treatment Decisions-Lessons Learned From Focus Groups.
PMID 27028481·JAMA Dermatol·2016
8-other
Anti-IL-23A mAb BI 655066 for treatment of moderate-to-severe psoriasis: Safety, efficacy, pharmacokinetics, and biomarker results of a single-rising-dose, randomized, double-blind, placebo-controlled trial.
PMID 25769911·J Allergy Clin Immunol·2015
2-rct

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Via practice · 5 locations total

Address
115 2nd Ave S Apt 1415
Minneapolis, MN 55401

Locations (5)

Practice Location

115 2nd Ave S Apt 1415, Minneapolis, MN
(201) 952-0584

Practice Location

909 FULTON ST SE, MINNEAPOLIS, MN
(612) 672-7422

Practice Location

500 HARVARD ST SE, MINNEAPOLIS, MN
(612) 626-3343

Practice Location

2820 SE 3RD CT STE 200, OCALA, FL
(352) 401-8817

Practice Location

1210 W 18TH ST STE 100, SIOUX FALLS, SD
(605) 312-8500

Quick Facts

NPI
1841426400
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
6
Locations
5
Years in Practice
17
Clinical Trials
1
Publications
20

Are you this provider?

Claim Your Profile